Suppr超能文献

秘鲁导致宫颈癌的人乳头瘤病毒类型及辅助因素。

HPV types and cofactors causing cervical cancer in Peru.

作者信息

Santos C, Muñoz N, Klug S, Almonte M, Guerrero I, Alvarez M, Velarde C, Galdos O, Castillo M, Walboomers J, Meijer C, Caceres E

机构信息

Instituto de Enfermedades Neoplásicas Dr Eduardo Cáceres Graziani, Av. Angamos Este 2520, Lima 34, Peru.

出版信息

Br J Cancer. 2001 Sep 28;85(7):966-71. doi: 10.1054/bjoc.2001.1948.

Abstract

We conducted a hospital-based case-control study in Peru of 198 women with histologically confirmed cervical cancer (173 squamous cell carcinomas and 25 cases of adenocarcinoma/adenosquamous carcinoma) and 196 control women. Information on risk factors was obtained by personal interview. Using PCR-based assays on exfoliated cervical cells and biopsy specimens, HPV DNA was detected in 95.3% of women with squamous cell carcinoma and in 92.0% of women with adenocarcinoma/adenosquamous carcinoma compared with 17.7% in control women. The age-adjusted odds ratio was 116.0 (95% Cl = 48.6-276.0) for squamous cell carcinoma and 51.4 (95% Cl = 11.4-232.0) for adenocarcinoma/adenosquamous carcinoma. The commonest types in women with cervical cancer were HPV 16, 18, 31, 52 and 35. The association with the various HPV types was equally strong for the two most common types (HPV 16 and 18) as for the other less common types. In addition to HPV, long-term use of oral contraceptives and smoking were associated with an increased risk. HPV is the main cause of both squamous cell carcinoma and adenocarcinoma in Peruvian women.

摘要

我们在秘鲁开展了一项基于医院的病例对照研究,研究对象为198名经组织学确诊为宫颈癌的女性(173例鳞状细胞癌和25例腺癌/腺鳞癌)以及196名对照女性。通过个人访谈获取风险因素信息。利用基于聚合酶链反应(PCR)的检测方法对脱落的宫颈细胞和活检标本进行检测,结果显示,鳞状细胞癌女性中95.3%检测到人乳头瘤病毒(HPV)DNA,腺癌/腺鳞癌女性中92.0%检测到HPV DNA,而对照女性中这一比例为17.7%。鳞状细胞癌的年龄调整优势比为116.0(95%可信区间=48.6 - 276.0),腺癌/腺鳞癌的年龄调整优势比为51.4(95%可信区间=11.4 - 232.0)。宫颈癌女性中最常见的HPV类型为16、18、31、52和35型。两种最常见的HPV类型(HPV 16和18)与其他较不常见类型相比,与各种HPV类型的关联强度相同。除HPV外,长期使用口服避孕药和吸烟也与风险增加有关。HPV是秘鲁女性鳞状细胞癌和腺癌的主要病因。

相似文献

1
HPV types and cofactors causing cervical cancer in Peru.
Br J Cancer. 2001 Sep 28;85(7):966-71. doi: 10.1054/bjoc.2001.1948.
2
Causes of cervical cancer in the Philippines: a case-control study.
J Natl Cancer Inst. 1998 Jan 7;90(1):43-9. doi: 10.1093/jnci/90.1.43.
3
Risk factors for cervical cancer in Thailand: a case-control study.
J Natl Cancer Inst. 1998 Jan 7;90(1):50-7. doi: 10.1093/jnci/90.1.50.
6
Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Cancer. 1996 Jun 1;77(11):2275-9. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2275::AID-CNCR14>3.0.CO;2-U.
7
Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.
Lancet. 2002 Mar 30;359(9312):1093-101. doi: 10.1016/S0140-6736(02)08151-5.
10
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
N Engl J Med. 1999 Nov 25;341(22):1633-8. doi: 10.1056/NEJM199911253412201.

引用本文的文献

1
Prevalence OF HPV IN a Peruvian Healthcare Network: A Descriptive Cross-Sectional Study.
Cancer Control. 2025 Jan-Dec;32:10732748251318386. doi: 10.1177/10732748251318386.
2
Staging and Management of Cervical Cancer at the Colposcopy Clinic of Bangabandhu Sheikh Sheikh Mujib Medical University (BSMMU), Bangladesh.
South Asian J Cancer. 2024 Feb 21;13(1):17-26. doi: 10.1055/s-0043-1776288. eCollection 2024 Jan.
3
The contribution of Latin American research to HPV epidemiology and natural history knowledge.
Braz J Med Biol Res. 2020 Jan 31;53(2):e9560. doi: 10.1590/1414-431X20199560. eCollection 2020.
5
Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile.
BMC Cancer. 2017 Aug 3;17(1):518. doi: 10.1186/s12885-017-3496-x.
6
Targeting women with free cervical cancer screening: challenges and lessons learnt from Osun state, southwest Nigeria.
Pan Afr Med J. 2016 Aug 19;24:319. doi: 10.11604/pamj.2016.24.319.9300. eCollection 2016.
7
Human papillomavirus genotypes distribution in cervical cancer cases in Gabon.
Infect Agent Cancer. 2016 Aug 16;11:42. doi: 10.1186/s13027-016-0091-8. eCollection 2016.
8
Control of cervical cancer in Peru: Current barriers and challenges for the future.
Mol Clin Oncol. 2016 Aug;5(2):241-245. doi: 10.3892/mco.2016.926. Epub 2016 Jun 10.
9
High HPV prevalence and need for ancillary care.
Braz J Infect Dis. 2015 Jan-Feb;19(1):110. doi: 10.1016/j.bjid.2014.09.003. Epub 2014 Dec 15.

本文引用的文献

5
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
J Pathol. 1999 Sep;189(1):12-9. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.
6
The viral origin of cervical cancer in Rabat, Morocco.
Int J Cancer. 1998 Feb 9;75(4):546-54. doi: 10.1002/(sici)1097-0215(19980209)75:4<546::aid-ijc9>3.0.co;2-t.
7
Risk factors for cervical cancer in Thailand: a case-control study.
J Natl Cancer Inst. 1998 Jan 7;90(1):50-7. doi: 10.1093/jnci/90.1.50.
8
Causes of cervical cancer in the Philippines: a case-control study.
J Natl Cancer Inst. 1998 Jan 7;90(1):43-9. doi: 10.1093/jnci/90.1.43.
10
Human papillomavirus and invasive cervical cancer in Brazil.
Br J Cancer. 1994 Jan;69(1):114-9. doi: 10.1038/bjc.1994.18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验